Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: Implications for treatment duration

Journal of Paediatrics and Child Health
Julie M CrosswellDiana R Lennon

Abstract

The aim of this study was to determine the time and total cumulative dose of parenteral antibiotic, required to sterilize the cerebrospinal fluid (CSF) of children presenting with meningococcal meningitis (MM). The study was a retrospective audit of children aged 0-14 years who presented between January 1995 and December 1999 with MM. All cases had a delayed lumbar puncture (LP) at least 1 h after commencing antibiotic therapy and demonstrated at least one of the following: (i) a positive CSF culture of Neisseria meningitidis (n = 6); (ii) Gram negative diplococci on Gram stain (n = 16) or (iii) a positive CSF plasma clearance rate test for N. meningitidis (n = 26). Forty-eight children were identified with a mean age of 4.4 years. The cumulative dose of antibiotic prior to LP, ranged from 22 to 440 mg/kg body weight. All cases (n = 24) who received a cumulative dose of at least 150 mg/kg of antibiotic, prior to LP, had a sterile CSF. No CSF taken more than 5 h after commencing antibiotics grew N. meningitidis. Children in this study with MM had rapid sterilisation of the CSF in less than 6 h. This would support recent recommendations to reduce the duration of antibiotic therapy to 4 days. There is however, lack of long-term da...Continue Reading

References

Jan 1, 1979·Transactions of the Royal Society of Tropical Medicine and Hygiene·J T MacfarlaneB M Greenwood
Jan 1, 1979·Transactions of the Royal Society of Tropical Medicine and Hygiene·S S WaliB M Greenwood
Dec 1, 1991·Clinical Pediatrics·M I Marks
Oct 1, 1988·The Pediatric Infectious Disease Journal·A M TuncerS Tuncer
Feb 1, 1988·The Pediatric Infectious Disease Journal·K ChughK K Joshi
Mar 1, 1995·Acta Paediatrica·P E NielsenM Tvede
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·C H ChiuY C Huang
Dec 1, 1996·The Pediatric Infectious Disease Journal·C A Arango, M H Rathore
Nov 5, 1997·BMJ : British Medical Journal·K Cartwright, S Kroll
Feb 18, 1998·The Journal of Infectious Diseases·D R MartinD R Lennon
Jul 2, 1998·International Journal of Impotence Research·S L Mills
May 1, 2001·Journal of Paediatrics and Child Health·D Lennon
Mar 12, 2002·Journal of Paediatrics and Child Health·M G BakerD Lennon

❮ Previous
Next ❯

Citations

Aug 30, 2017·Archives of Disease in Childhood·Marita Macken, Ian D Wacogne
Oct 2, 2019·Praxis·Rahel Maria KindlerDoris Madörin
Dec 3, 2016·Journal of Global Health·Yaowen ZhangMoe H Kyaw

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Allan R TunkelRichard J Whitley
Lancet
Xavier Sáez-Llorens, George H McCracken
The Lancet Infectious Diseases
Michael T Fitch, Diederik van de Beek
© 2022 Meta ULC. All rights reserved